↓ Skip to main content

Substandard and falsified ivermectin tablets obtained for self‐medication during the COVID‐19 pandemic as a source of potential harm

Overview of attention for article published in Drug Testing and Analysis, December 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#18 of 1,591)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
187 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Substandard and falsified ivermectin tablets obtained for self‐medication during the COVID‐19 pandemic as a source of potential harm
Published in
Drug Testing and Analysis, December 2023
DOI 10.1002/dta.3618
Pubmed ID
Authors

Celine Vanhee, Bram Jacobs, Angélique Kamugisha, Michael Canfyn, Hans Van Der Meersch, Bart Ceyssens, Eric Deconinck, Koenraad Van Hoorde, Marie Willocx

X Demographics

X Demographics

The data shown below were collected from the profiles of 187 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 57%
Student > Ph. D. Student 1 14%
Unknown 2 29%
Readers by discipline Count As %
Unspecified 4 57%
Pharmacology, Toxicology and Pharmaceutical Science 1 14%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 134. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2024.
All research outputs
#331,938
of 26,557,909 outputs
Outputs from Drug Testing and Analysis
#18
of 1,591 outputs
Outputs of similar age
#5,525
of 394,792 outputs
Outputs of similar age from Drug Testing and Analysis
#1
of 40 outputs
Altmetric has tracked 26,557,909 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,591 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 394,792 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.